POC Molecular System


Accurate/ Accesible/ Actionable
diagnosis for better healthcare


What We Do

We design, manufacture and commercialize next generation molecular diagnostic tests, bringing the superior diagnostics performance of PCR to the point-of-care (POC).

Our Goal

We strive to bring DNA and RNA testing to a much larger population segment than alternative, legacy solutions so healthcare providers can more effectively treat patients.

Our Technology

Our proprietary OSCAR technology is key to our patented and patent-pending diagnostic solutions. Our revolutionary technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity, specificity of laboratory-based molecular testing.


Our Products

The PCR test technology developed by Mesa Biotech enables healthcare professionals to access actionable, laboratory-quality results at the Point of Care:

  • Mesa Biotech’s Accula System consists of a portable, palm-sized dock and assay-specific test cassettes

  • Superior diagnostics performance of nucleic acid PCR

  • Near patient results to start effective treatment

  • Accula FluA/B and Accula RSV are CE Marked, 510 (K) cleared and CLIA Waived

Accula Dock


Flu A / Flu B

Accula RSV

Products which are being developed or under clinical trials.

with connectivity

Accula Strep A




HSV 1+2 / VZV